Anesthetic Pharmacology and Perioperative Considerations for the End Stage Liver Disease Patient

ISSN: 2212-3938 (Online)
ISSN: 1574-8847 (Print)


Volume 9, 4 Issues, 2014


Download PDF Flyer




Current Clinical Pharmacology

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Arduino A. Mangoni
Flinders University and Flinders Medical Centre
Adelaide, SA
Australia


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Anesthetic Pharmacology and Perioperative Considerations for the End Stage Liver Disease Patient

Author(s): Robert L. Mcclain, Harish Ramakrishna, Stephen Aniskevich, Joseph A. Cartwright, Leah G. Ward, Sher-Lu Pai, Eduardo S. Rodrigues, Archer K. Martin and Timothy S. Shine

Affiliation: Department of Anesthesiology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL 32224, USA

Abstract

The number of patients with end stage liver disease is growing worldwide. This is likely a result of advances in medical science that have allowed these patients to lead longer lives since the incidence of diseases such as alcoholic cirrhosis and viral hepatitis have remained stable or even decreased in recent years, at least in more developed nations. Many of these patients will require anesthetic care at some point. The understanding and application of basic principles of pharmacokinetics is paramount to the practice of anesthesia. An understanding of pharmacokinetic principles provides the anesthesiologist with a scientific foundation for achieving therapeutic objectives associated with the use of any drug; however, pathologic conditions often alter the expected kinetic profile of many drugs. This is particularly true in the anesthetic management of the patient with hepatic pathology as the liver plays a central role in the absorption, distribution, and elimination kinetics of most drugs and many active and inactive drug metabolites. We review normal liver physiology, pathophysiology of liver disease in general, and how liver failure affects the pharmacokinetics and pharmacodynamics of anesthetic agents; providing some specific examples

Keywords: Anesthesia, end stage liver disease, hepatic failure, liver transplant, pharmacodynamics, pharmacology

Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 9
First Page: 1
Last Page: 12
Page Count: 12
DOI: 10.2174/1574884709666140212110036
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science